HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: gut.2005.071423v1 55/6/878    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eapen, C E Articles by Elias, E Search for Related Content PubMed PubMed Citation Articles by Eapen, C E Articles by Elias, E Topic Collections Relevant Article

Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome

¹ Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
² Radiology Department, Queen Elizabeth Hospital, Birmingham, UK

Correspondence to:
Correspondence to:
Professor E Elias
Liver Unit, Queen Elizabeth Hospital, 3rd Floor, Nuffield House, Edgbaston, Birmingham B15 2TH, UK; Elwyn.Elias{at}uhb.nhs.uk

Background: We report our experience with management of patients with Budd Chiari syndrome over the past two decades. In 1996 we described a novel approach involving recanalisation of hepatic veins by combined percutaneous and transvenous approaches. This was incorporated into an algorithm published in 1999 in which our preferred treatment for all cases of Budd Chiari syndrome with short segment occlusion or stenosis of the hepatic veins involves recanalisation of the hepatic veins by transvenous or combined percutaneous-transvenous approaches. In symptomatic Budd Chiari syndrome where recanalisation is not possible, we perform transjugular intrahepatic portosystemic shunts (TIPS) because TIPS decompresses the portal circulation directly in an adjustable way. In this series of patients with Budd Chiari syndrome treated with radiological interventions alone, we assess their medium term outcome using two independent objective prognostic indices.

Methods: We retrospectively studied 61 patients with non-malignant Budd Chiari syndrome treated by radiological intervention alone in our centre.

Results: Actuarial survival for the entire cohort at one year and five years was 94% and 87%, respectively. Survival of our patients with mild disease (according to the Murad classification) was 100% at one year and at five years, with intermediate disease severity 94% at one year and 86% at five years, and with severe disease 85% at one year and 77% at five years.

Conclusion: Management of Budd Chiari syndrome by interventional radiology resulted in excellent medium term survival for patients in all categories of disease severity.

Abbreviations: TIPS, transjugular intrahepatic portosystemic shunt; MELD, model for end stage liver disease

Keywords: Budd Chiari syndrome; hepatic vein recanalisation; interventional radiology; recanalisation; transjugular intrahepatic portosystemic shunt

Relevant Article

Prognosis in Budd Chiari syndrome after re-establishing hepatic venous drainage

D-C Valla
Gut 2006 55: 761-763. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				D-C Valla Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome Gut, October 1, 2008; 57(10): 1469 - 1478. [Full Text] [PDF]

				R Moucari, P-E Rautou, D Cazals-Hatem, A Geara, C Bureau, Y Consigny, C Francoz, M-H Denninger, V Vilgrain, J Belghiti, et al. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors Gut, June 1, 2008; 57(6): 828 - 835. [Abstract] [Full Text] [PDF]

				D-C Valla Prognosis in Budd Chiari syndrome after re-establishing hepatic venous drainage. Gut, June 1, 2006; 55(6): 761 - 763. [Full Text] [PDF]